Skip to main content
logo
J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,190
+630 (5.97%)
At close: Aug 11, 2026

J2KBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36,82432,96633,12928,47216,03214,219
Revenue Growth
13.00%-0.49%16.36%77.60%12.75%2.60%
Gross Profit
14,67912,97912,65711,5027,0585,929
Operating Income
4,5032,9203,6265,6072,3241,874
Net Income
4,0292,673-1,6534,8442,0861,623
Earnings Per Share
690.98458.84-299.00978.27414.4426241.41
EPS Growth
35.99%--136.05%-98.42%10.01%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9,32612,70113,0544,4015,0994,923
Total Debt
1,0601,1352,0881,2464,5905,248
Net Cash (Debt)
8,26611,56610,9663,156508.96-324.19
Net Cash Growth
-12.48%5.48%247.50%520.00%--
Net Cash Per Share
1417.741985.531983.98625.86100.95-5241.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,1202,0786,9283,2851,4482,001
Capital Expenditures
-421.69-866.78-6,904-1,369-119.66-798.8
Free Cash Flow
2,6991,21123.371,9161,3281,203
Free Cash Flow Growth
-5079.88%-98.78%44.27%10.43%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.86%39.37%38.20%40.40%44.02%41.70%
Operating Margin
12.23%8.86%10.95%19.69%14.49%13.18%
Pretax Margin
12.22%9.23%-4.11%19.57%13.62%11.21%
Profit Margin
10.94%8.11%-4.99%17.01%13.01%11.42%
FCF Margin
7.33%3.67%0.07%6.73%8.28%8.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.1918.82----
P/FCF Ratio
24.2541.542224.56---
PS Ratio
1.781.531.57---